Oncolytics Biotech Balance Sheet (2009-2026)

Reported Financials

Oncolytics Biotech Quarterly Balance Sheet

Periods 69 quarters

Latest Jun 2026

Oncolytics Biotech reported total assets of $0.01B and total liabilities of $0.01B for the quarter ended Jun 2026, down 44.1% year over year. This balance sheet covers 69 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Receivables - AccuredAcc. Int. Receivables
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.04B	0.04B	0.03B	0.03B	0.03B	0.02B	0.01B	0.01B	0.01B	0.03B	0.03B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B
Receivables - NetNet Receivables
Receivables - OtherOther Receivables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Receivables
Prepaid Assets	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Current Assets	0.05B	0.04B	0.04B	0.03B	0.03B	0.03B	0.03B	0.03B	0.02B	0.03B	0.03B	0.02B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Non-Current Assets
Property, Plant & Equipment (Net)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Long-Term Investments
Intangibles
Goodwill & Intangibles
Other Non-Current Assets
Non-Current Assets	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Assets	0.05B	0.04B	0.04B	0.04B	0.03B	0.03B	0.03B	0.03B	0.02B	0.03B	0.03B	0.03B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Liabilities
Current Liabilities
Accounts Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B
Notes Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B
Accumulated Expenses															0.00B				0.00B	0.00B
Other Accumulated Expenses	-0.00B		0.00B							0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Current Leases	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Current Taxes
Current Deferred Revenue
Total Current Liabilities	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B
Non-Current Liabilities
Non-Current Deffered Revenue	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Operating Leases	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non-Current Liabilities	0.00B	0.00B	0.00B	0.00B
Total Non-Current Liabilities	0.01B	0.01B	0.00B	0.00B			0.01B
Total Liabilities	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Shareholder's Equity
Total Debt	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Common Equity	0.04B	0.03B	0.03B	0.03B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.01B
Liabilities and Shareholders Equity	0.05B	0.04B	0.04B	0.04B	0.03B	0.03B	0.03B	0.03B	0.02B	0.03B	0.03B	0.03B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Retained Earnings	-0.31B	-0.31B	-0.31B	-0.32B	-0.32B	-0.31B	-0.31B	-0.31B	-0.32B	-0.33B	-0.33B	-0.34B	-0.34B	-0.34B	-0.34B	-0.34B	-0.35B	-0.37B	-0.43B	-0.45B

Oncolytics Biotech ONCY Balance Sheet (2009-2026)

Oncolytics Biotech Quarterly Balance Sheet

Create an account

Sign In

Reset Password